Joong In Lim Selected Research

4-aminomethyl-1,2-naphthoquinone

1/2004

Anti-diabetic effects of DA-11004, a synthetic IDPc inhibitor in high fat high sucrose diet-fed C57BL/6J mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joong In Lim Research Topics

Disease

3	Insulin Resistance 01/2011 - 10/2008
1	Hyperglycemia 01/2011
1	Edema (Dropsy) 09/2010
1	Hepatocellular Carcinoma (Hepatoma) 10/2008
1	Body Weight (Weight, Body) 01/2004
1	Obesity 01/2004

Drug/Important Bio-Agent (IBA)

3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011 - 10/2008
2	Glucose (Dextrose)FDA LinkGeneric 10/2008 - 01/2004
1	2- ethoxy- 3- (4- (3- methyl- 5- (4- (3- methylisoxazol- 5- yl)phenyl)thiophen- 2- ylmethoxy)phenyl)propionic acidIBA 01/2011
1	Pharmaceutical PreparationsIBA 09/2010
1	PPAR gammaIBA 05/2009
1	Insulin (Novolin)FDA Link 10/2008
1	LipidsIBA 10/2008
1	(3- (4- (2(4- (4chloro- phenyl)- 3,6- dihydro- 2H- pyridin- 1- yl)- ethoxy)- phenyl)- (2S)- ethoxy- propionic acid)IBA 10/2008
1	PPAR alphaIBA 10/2008
1	4-aminomethyl-1,2-naphthoquinoneIBA 01/2004
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2004
1	Sucrose (Saccharose)IBA 01/2004